LeMaitre Vascular Statistics
Share Statistics
LeMaitre Vascular has 22.48M shares outstanding. The number of shares has increased by 0.92% in one year.
Shares Outstanding | 22.48M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 0.1% |
Owned by Institutions (%) | n/a |
Shares Floating | 20.50M |
Failed to Deliver (FTD) Shares | 108 |
FTD / Avg. Volume | 0.09% |
Short Selling Information
The latest short interest is 784.46K, so 3.49% of the outstanding shares have been sold short.
Short Interest | 784.46K |
Short % of Shares Out | 3.49% |
Short % of Float | 3.83% |
Short Ratio (days to cover) | 7.46 |
Valuation Ratios
The PE ratio is 41.89 and the forward PE ratio is 47.59. LeMaitre Vascular 's PEG ratio is 0.64.
PE Ratio | 41.89 |
Forward PE | 47.59 |
PS Ratio | 6.52 |
Forward PS | 9.5 |
PB Ratio | 4.23 |
P/FCF Ratio | 42.77 |
PEG Ratio | 0.64 |
Enterprise Valuation
LeMaitre Vascular Inc. has an Enterprise Value (EV) of 1.26B.
EV / Earnings | 41.72 |
EV / Sales | 6.49 |
EV / EBITDA | 25.64 |
EV / EBIT | 33.87 |
EV / FCF | 42.59 |
Financial Position
The company has a current ratio of 6.51, with a Debt / Equity ratio of 0.01.
Current Ratio | 6.51 |
Quick Ratio | 4.76 |
Debt / Equity | 0.01 |
Total Debt / Capitalization | 0.82 |
Cash Flow / Debt | 14.87 |
Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0.1% and return on capital (ROIC) is 8.92%.
Return on Equity (ROE) | 0.1% |
Return on Assets (ROA) | 0.09% |
Return on Capital (ROIC) | 8.92% |
Revenue Per Employee | 315.12K |
Profits Per Employee | 49.03K |
Employee Count | 614 |
Asset Turnover | 0.56 |
Inventory Turnover | 1.27 |
Taxes
Income Tax | 9.37M |
Effective Tax Rate | 0.24 |
Stock Price Statistics
The stock price has increased by 80.5% in the last 52 weeks. The beta is 0.89, so LeMaitre Vascular 's price volatility has been higher than the market average.
Beta | 0.89 |
52-Week Price Change | 80.5% |
50-Day Moving Average | 97.17 |
200-Day Moving Average | 83.11 |
Relative Strength Index (RSI) | 47.98 |
Average Volume (20 Days) | 126.43K |
Income Statement
In the last 12 months, LeMaitre Vascular had revenue of $193.48M and earned $30.11M in profits. Earnings per share was $1.36.
Revenue | 193.48M |
Gross Profit | 127.05M |
Operating Income | 37.08M |
Net Income | 30.11M |
EBITDA | 48.99M |
EBIT | 37.08M |
Earnings Per Share (EPS) | 1.36 |
Balance Sheet
The company has $24.27M in cash and $19.09M in debt, giving a net cash position of $5.17M.
Cash & Cash Equivalents | 24.27M |
Total Debt | 19.09M |
Net Cash | 5.17M |
Retained Earnings | 115.43M |
Total Assets | 377.02M |
Working Capital | 197.77M |
Cash Flow
In the last 12 months, operating cash flow was $36.75M and capital expenditures -$7.26M, giving a free cash flow of $29.49M.
Operating Cash Flow | 36.75M |
Capital Expenditures | -7.26M |
Free Cash Flow | 29.49M |
FCF Per Share | 1.33 |
Margins
Gross margin is 65.66%, with operating and profit margins of 19.17% and 15.56%.
Gross Margin | 65.66% |
Operating Margin | 19.17% |
Pretax Margin | 20.4% |
Profit Margin | 15.56% |
EBITDA Margin | 25.32% |
EBIT Margin | 19.17% |
FCF Margin | 15.24% |
Dividends & Yields
LMAT pays an annual dividend of $0.64, which amounts to a dividend yield of 0.64%.
Dividend Per Share | $0.64 |
Dividend Yield | 0.64% |
Dividend Growth (YoY) | 14.29% |
Payout Ratio | 35.16% |
Earnings Yield | 1.36% |
FCF Yield | 1.31% |
Analyst Forecast
The average price target for LMAT is $96, which is -4.3% lower than the current price. The consensus rating is "Buy".
Price Target | $96 |
Price Target Difference | -4.3% |
Analyst Consensus | Buy |
Analyst Count | 7 |
Scores
Altman Z-Score | 31.8 |
Piotroski F-Score | 7 |